Q2 2026 sales backlog
Company: CoreWeave
The claim, verbatim
CoreWeave reported Q2 2026 sales backlog of $104 billion
Source (primary)
‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - TradingView (-, news_article)
View cached copy (2026-09-01)Live source ↗
Quote: “The company's sales backlog – or future sales from recurring customers – reached $104 billion, nearly doubling the order book it reported in November.”
How we checked this
Checked on September 15, 2026. The cited source supports every part of this claim.
The article says CoreWeave's sales backlog reached $104 billion in the second-quarter results released Aug. 11, when it also raised its full-year 2026 guidance.
Confirmed in the source:
- CoreWeave's sales backlog reached $104 billion in its second-quarter results
- The quarter is in 2026, as shown by results issued Aug. 11 alongside raised full-year 2026 guidance
What we did: Read our cached copy of the publisher (https://www.tradingview.com/news/stocktwits:3ac1780d8094b:0-pharma-bro-martin-shkreli-covered-coreweave-short-position-crwv-stock-slides-for-third-session/) in full (5,190 characters, retrieved September 1, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms ‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - TradingView
Quote: “The company's sales backlog – or future sales from recurring customers – reached $104 billion, nearly doubling the order book it reported in November.”